changi general hospital
Singapore’s First Influenza Vaccine Shows Favorable Immunogenicity
Singapore first influenza vaccine has met its primary endpoint for immunogenicity in the Phase 1 clinical trial in healthy Asian volunteers.
Diabetes Sufferers May Have Abnormal Gut Taste Mechanisms
Researchers have discovered that the way the gut "tastes" sweet food may be defective in sufferers of type 2 diabetes.
H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.





